AK Medical to Recommend HK$0.118 Final Dividend, Re-elect Directors and Seek Fresh Share Mandates at 17 June AGM

Bulletin Express
04/28

AK Medical Holdings Limited has released its 2026 AGM circular detailing proposals to be tabled on 17 June 2026 in Beijing.

Dividend • The Board recommends a final dividend of HK$0.118 per share for FY 2025, up from HK$0.072 a year earlier. • Subject to shareholder approval, the dividend will be paid on or about 17 July 2026 to shareholders on record at 16:30 on 29 June 2026. • The register will be closed from 25 June to 29 June 2026; transfers must be lodged by 24 June 2026.

Board Elections • Executive Directors Li Zhijiang and Zhang Bin, and Non-executive Director Dr Wang David Guowei will retire by rotation and stand for re-election. • The Nomination Committee supports their reappointment, citing satisfactory performance and continued contribution to board diversity.

Auditors • The Board, in line with Audit Committee advice, proposes re-appointing KPMG for FY 2026 at an audit fee of RMB3.80–4.20 million.

Share Repurchase Mandate • Directors seek authority to repurchase up to 10% of issued shares—112.39 million shares based on the current 1.12 billion share capital. • Any repurchases will be funded from legally available resources and carried out within Listing Rules limits.

Share Issuance Mandate • A separate resolution requests authority to issue up to 20% of issued shares—224.78 million shares—and to extend the mandate by the number of shares repurchased.

Key Timetable • AGM record date: 11 June 2026 (register closed 12–17 June). • Dividend record date: 29 June 2026 (register closed 25–29 June). • Dividend payment: on or about 17 July 2026.

Capital Structure and Governance Notes • Outstanding shares: 1,123.92 million. • Controlling shareholders Li Zhijiang and Zhang Bin, with concert parties, hold 45.85% of issued shares; a full 10% buy-back would raise their interest to 50.94%, potentially triggering a Takeovers Code mandatory offer. The Board states it has no present intention to repurchase shares to that extent.

Shareholders will vote on all resolutions via poll at the AGM; proxy forms must be submitted by 10:00 on 15 June 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10